Results 261 to 270 of about 124,517 (353)

Association between diabetes and in‐hospital outcomes in patients with metabolic dysfunction‐associated steatotic liver disease hospitalized for cardiovascular disease: A nationwide database study

Diabetic Medicine, Volume 43, Issue 5, May 2026.
In a nationwide cohort of 10,614 patients with metabolic dysfunction–associated steatotic liver disease (MASLD) hospitalized for cardiovascular disease (CVD), diabetes was present in 4550 patients (43%) and was independently associated with higher in‐hospital mortality and cardiovascular complications.
Soichi Komaki, Michikazu Nakai, Yunosuke Matsuura, Kinuko Yamamoto, Hiroki Tanaka, Yuri Komaki, Masashi Yamaguchi, Kohei Moribayashi, Takeshi Ideguchi, Hiroshi Kawakami, Toshihiro Tsuruda, Koichi Kaikita   +11 more
wiley   +1 more source

Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis. [PDF]

Hepatol Commun
Beuers U, Rousseau A, van de Graaf SFJ, Corpechot C.   +3 more
europepmc   +1 more source

Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. [PDF]

, 1993
Abu-Elmagd, KM, Baddour, N, Demetris, AJ, Fung, J, Irish, W, Iwatsuki, S, Selby, R, Starzl, TE, Todo, S, Tzakis, A, Van Thiel, DH   +10 more
core  

Associations between use of aspirin and magnetic resonance imaging‐derived liver fat and fibroinflammation

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3895-3902, May 2026.
Abstract Background The effects of aspirin on hepatic steatosis and fibroinflammation are unclear. The study aimed to examine the association between aspirin use and liver magnetic resonance imaging (MRI)‐derived liver fat and corrected T1 (cT1). Methods We used UK Biobank imaging cohort data.
Qi Feng, Pinelopi Manousou, Chioma N. Izzi‐Engbeaya, Jun Liu, Mark Woodward   +4 more
wiley   +1 more source

Outcomes Following Antifungal Treatment for <i>Candida</i> Growth in Bile Cultures Collected During Endoscopic Retrograde Cholangiopancreatography. [PDF]

J Fungi (Basel)
Charpentier G, Smith KA, Slaven JE, Emeli TO, Susler RG, Chehab H, Gromski MA, Khan H, Gupta SK, Barros N.   +9 more
europepmc   +1 more source

Impact of Disease‐Specific Treatment and Non‐Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Background Portal vein thrombosis (PVT) is a common sequela of cirrhosis. Despite regression of fibrosis/cirrhosis observed among some patients after disease‐specific treatment, few studies have considered the role of treatment and response on risk of PVT among patients with cirrhosis across different liver disease states.
Humberto C. Gonzalez, Stuart C. Gordon, Sheri Trudeau, Trueman Wu, Lora Rupp, Christina Melkonian, Mark A. Schmidt, Yihe G. Daida, Amandeep K. Sahota, Christopher L. Bowlus, Mei Lu   +10 more
wiley   +1 more source

Correction to "Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER)". [PDF]

United European Gastroenterol J
europepmc   +1 more source

Rescue multihole metal stent placement to prevent stent migration after endoscopic ultrasound-guided hepaticogastrostomy. [PDF]

Endoscopy
Hara A, Minaga K, Otsuka Y, Takenaka M, Kudo M.   +4 more
europepmc   +1 more source

Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Background & Aims Baseline alkaline phosphatase (ALP) levels can influence the likelihood of achieving dichotomous biochemical response criteria in primary biliary cholangitis (PBC). This concept was explored using Week 52 data from the phase III ELATIVE trial (NCT04526665), which assessed elafibranor, a peroxisome proliferator‐activated ...
Cynthia Levy, Christopher L. Bowlus, Eric Lawitz, Nuno Antunes, Benjamin Miller, Jianfen Shu, Claudia O. Zein, Kris V. Kowdley   +7 more
wiley   +1 more source

IgG4-related sclerosing cholangitis: navigating diagnostic dilemmas and the challenge of relapse. [PDF]

Front Med (Lausanne)
Ren X, Jin X, Liu L, Zhang M.
europepmc   +1 more source